Targeting BCAT1 combined with alpha-ketoglutarate triggers metabolic synthetic lethality in glioblastoma. Zhang B, Peng H, Zhou M, Bao L, et al. Cancer Res 2022 May 2. pii: 696261. doi: 10.1158/0008-5472.CAN-21-3868.

Read + Share

Amedeo Smart

Independent Medical Education

Zhang B, Peng H, Zhou M, Bao L, et al. Targeting BCAT1 combined with alpha-ketoglutarate triggers metabolic synthetic lethality in glioblastoma. Cancer Res 2022 May 2. pii: 696261. doi: 10.1158/0008-5472.CAN-21-3868.
PMID: 35499760